 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
The Journal of Neuroscience, February 15, 2003, 23(4):1228
Synergistic Dopaminergic Neurotoxicity of the Pesticide Rotenone and Inflammogen Lipopolysaccharide: Relevance to the Etiology of Parkinson's Disease
Hui-Ming Gao1, 2, Jau-Shyong Hong1, Wanqin Zhang2, and Bin Liu1 1 Neuropharmacology Section, Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences/National Institutes of Health, Research Triangle Park, North Carolina 27709, and 2 Department of Physiology, Dalian Medical University, Dalian, 116027, China
Parkinson's disease (PD) is characterized by a progressive degeneration of the nigrostriatal dopaminergic pathway resulting in movement disorders. Although its etiology remains unknown, PD may be the final outcome of interactions among multiple factors, including exposure to environmental toxins and the occurrence of inflammation in the brain. In this study, using primary mesencephalic cultures, we observed that nontoxic or minimally toxic concentrations of the pesticide rotenone (0.5 nM) and the inflammogen lipopolysaccharide (LPS) (0.5 ng/ml) synergistically induced dopaminergic neurodegeneration. The synergistic neurotoxicity of rotenone and LPS was observed when the two agents were applied either simultaneously or in tandem. Mechanistically, microglial NADPH oxidase-mediated generation of reactive oxygen species appeared to be a key contributor to the synergistic dopaminergic neurotoxicity. This conclusion was based on the following observations. First, inhibition of NADPH oxidase or scavenging of free radicals afforded significant neuroprotection. Second, rotenone and LPS synergistically stimulated the NADPH oxidase-mediated release of the superoxide free radical. Third and most importantly, rotenone and LPS failed to induce the synergistic neurotoxicity as well as the production of superoxide in cultures from NADPH oxidase-deficient animals. This is the first demonstration that low concentrations of a pesticide and an inflammogen work in synergy to induce a selective degeneration of dopaminergic neurons. Findings from this study may be highly relevant to the elucidation of the multifactorial etiology of PD and the discovery of effective therapeutic agents for the treatment of the disease.
Key words: pesticide; inflammation; microglia; NADPH oxidase; Parkinson's disease; synergistic neurotoxicity
Copyright © 2003 Society for Neuroscience 0270-6474/03/2341228-09$05.00/0
This article has been cited by other articles:
H.-M. Gao, P. T. Kotzbauer, K. Uryu, S. Leight, J. Q. Trojanowski, and V. M.-Y. Lee
Neuroinflammation and Oxidation/Nitration of {alpha}-Synuclein Linked to Dopaminergic Neurodegeneration
J. Neurosci., July 23, 2008; 28(30): 7687 - 7698.
[Abstract] [Full Text] [PDF]
J. Wang and S. Dore
Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage
Brain, June 1, 2007; 130(6): 1643 - 1652.
[Abstract] [Full Text] [PDF]
L.-P. Liang, J. Huang, R. Fulton, B. J. Day, and M. Patel
An Orally Active Catalytic Metalloporphyrin Protects against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Neurotoxicity In Vivo
J. Neurosci., April 18, 2007; 27(16): 4326 - 4333.
[Abstract] [Full Text] [PDF]
M. P. Mount, A. Lira, D. Grimes, P. D. Smith, S. Faucher, R. Slack, H. Anisman, S. Hayley, and D. S. Park
Involvement of Interferon-{gamma} in Microglial-Mediated Loss of Dopaminergic Neurons
J. Neurosci., March 21, 2007; 27(12): 3328 - 3337.
[Abstract] [Full Text] [PDF]
S. Yang, J. Yang, Z. Yang, P. Chen, A. Fraser, W. Zhang, H. Pang, X. Gao, B. Wilson, J.-S. Hong, et al.
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) 38 and PACAP4-6 Are Neuroprotective through Inhibition of NADPH Oxidase: Potent Regulators of Microglia-Mediated Oxidative Stress
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 595 - 603.
[Abstract] [Full Text] [PDF]
Y. Zhou, Y. Wang, M. Kovacs, J. Jin, and J. Zhang
Microglial Activation Induced by Neurodegeneration: A Proteomic Analysis
Mol. Cell. Proteomics, October 1, 2005; 4(10): 1471 - 1479.
[Abstract] [Full Text] [PDF]
S M Hague, S Klaffke, and O Bandmann
Neurodegenerative disorders: Parkinson's disease and Huntington's disease
J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1058 - 1063.
[Abstract] [Full Text] [PDF]
W. Zhang, T. Wang, Z. Pei, D. S. Miller, X. Wu, M. L. Block, B. Wilson, W. Zhang, Y. Zhou, J.-S. Hong, et al.
Aggregated {alpha}-synuclein activates microglia: a process leading to disease progression in Parkinson's disease
FASEB J, April 1, 2005; 19(6): 533 - 542.
[Abstract] [Full Text] [PDF]
L. Qin, M. L. Block, Y. Liu, R. J. Bienstock, Z. Pei, W. Zhang, X. Wu, B. Wilson, T. Burka, and J.-S. Hong
Microglial NADPH oxidase is a novel target for femtomolar neuroprotection against oxidative stress
FASEB J, April 1, 2005; 19(6): 550 - 557.
[Abstract] [Full Text] [PDF]
S. Cho, E.-M. Park, M. Febbraio, J. Anrather, L. Park, G. Racchumi, R. L. Silverstein, and C. Iadecola
The Class B Scavenger Receptor CD36 Mediates Free Radical Production and Tissue Injury in Cerebral Ischemia
J. Neurosci., March 9, 2005; 25(10): 2504 - 2512.
[Abstract] [Full Text] [PDF]
L. Qin, Y. Liu, T. Wang, S.-J. Wei, M. L. Block, B. Wilson, B. Liu, and J.-S. Hong
NADPH Oxidase Mediates Lipopolysaccharide-induced Neurotoxicity and Proinflammatory Gene Expression in Activated Microglia
J. Biol. Chem., January 9, 2004; 279(2): 1415 - 1421.
[Abstract] [Full Text] [PDF]
H.-M. Gao, B. Liu, and J.-S. Hong
Critical Role for Microglial NADPH Oxidase in Rotenone-Induced Degeneration of Dopaminergic Neurons
J. Neurosci., July 16, 2003; 23(15): 6181 - 6187.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|